Ventripoint Diagnostics Ltd (VPT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55 | 61 | 1,294 | 5,186 | 9,269 |
| Receivables | 133 | 251 | 285 | 374 | 197 |
| TOTAL | $350 | $474 | $1,637 | $5,663 | $9,502 |
| Non-Current Assets | |||||
| PPE Net | 122 | 184 | 247 | 313 | 43 |
| TOTAL | $122 | $184 | $247 | $313 | $43 |
| Total Assets | $472 | $658 | $1,883 | $5,977 | $9,545 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,422 | 1,357 | 60 | 50 | N/A |
| Accounts payable and accrued liabilities | 1,357 | 1,700 | 949 | 842 | 989 |
| Accrued Expenses | 602 | 295 | 301 | 122 | 62 |
| TOTAL | $4,473 | $3,427 | $1,397 | $1,056 | $1,085 |
| Non-Current Liabilities | |||||
| Long Term Debt | 36 | 59 | 78 | 93 | 125 |
| Deferred Revenues | 18 | 10 | 32 | N/A | N/A |
| TOTAL | $115 | $212 | $297 | $367 | $125 |
| Total Liabilities | $4,589 | $3,640 | $1,694 | $1,423 | $1,211 |
| Shareholders' Equity | |||||
| Common Shares | 44,766 | 43,777 | 42,675 | 42,675 | 42,214 |
| Retained earnings | -61,613 | -58,413 | -53,493 | -48,621 | -43,748 |
| Other shareholders' equity | 512 | 45 | 93 | 78 | 112 |
| TOTAL | $-4,117 | $-2,982 | $190 | $4,554 | $8,334 |
| Total Liabilities And Equity | $472 | $658 | $1,883 | $5,977 | $9,545 |